MedPath

Inventprise, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Phase 2
Active, not recruiting
Conditions
Pneumococcal Disease, Invasive
Interventions
Biological: Formulation B
Biological: Formulation C
First Posted Date
2025-01-24
Last Posted Date
2025-04-16
Lead Sponsor
Inventprise Inc.
Target Recruit Count
421
Registration Number
NCT06790290
Locations
🇵🇭

Health Index Multispecialty Clinic, Bacoor, Cavite, Philippines

🇵🇭

Grand Centennial Homes Clinic, Kawit, Cavite, Philippines

🇵🇭

University of the Philippines-National Health Institute_Doña Nena Health Center, Pasay, Metro Manila, Philippines

Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.

Phase 1
Recruiting
Conditions
Group B Streptococcal Infections
Interventions
Biological: IVT GBS-06
Biological: Placebo
First Posted Date
2024-09-24
Last Posted Date
2025-01-17
Lead Sponsor
Inventprise Inc.
Target Recruit Count
600
Registration Number
NCT06611371
Locations
🇺🇸

NYU Grossman School of Medicine, New York, New York, United States

🇿🇦

Wits Vaccines and Infectious Diseases Analytics Research Unit (Wits-VIDA), University of the Witwatersrand, Johannesburg, Gauteng, South Africa

Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

Phase 2
Active, not recruiting
Conditions
Pneumococcal Vaccines
Interventions
Biological: IVT PCV-25 Formulation C
Biological: IVT PCV-25 Formulation A
Biological: PCV 20
Biological: IVT PCV-25 Formulation B
First Posted Date
2023-10-11
Last Posted Date
2023-12-13
Lead Sponsor
Inventprise Inc.
Target Recruit Count
220
Registration Number
NCT06077656
Locations
🇨🇦

Inventprise Clinical Site, Saint Louis, Quebec, Canada

Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine

Phase 1
Completed
Conditions
Pneumococcal Vaccines
Interventions
Biological: IVT PCV-25
Biological: PCV 20
First Posted Date
2022-09-14
Last Posted Date
2023-08-30
Lead Sponsor
Inventprise Inc.
Target Recruit Count
65
Registration Number
NCT05540028
Locations
🇨🇦

Canadian Center for Vaccinology, IWK Health Centre, Halifax, Nova Scotia, Canada

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy